Abbott study shows continuous glucose monitoring outperforms fingersticks in Type 2 diabetes
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
One task, one interaction, one pair, experts advocate
The Japan Patent Office is considered one of the world's most rigorous and meticulous in its review process
Diasens and GlucoLive are designed for diabetic, Chronic Kidney Disease (CKD), and post-transplant patients who require continuous glycaemic surveillance and integrated remote care
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
Indomo’s ClearPen system combines a proprietary self-injection device and microneedle with a modernized triamcinolone acetonide formulation
Germany will be the first launch market
Subscribe To Our Newsletter & Stay Updated